CDK 2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP 110
暂无分享,去创建一个
E. Dmitrovsky | I. Wistuba | A. Andrew | C. Behrens | C. Moran | D. Compton | J. Rodriguez-Canales | D. Sekula | L. Mustachio | S. Ravi | L. Tafe | S. Freemantle | V. Memoli | A. Danilov | B. Mino | Yun Lu | F. Galimberti | Shanhu Hu | B. Orr | AndrewDeCastro | Kristina M. Godek
[1] M. Pagano,et al. USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110 , 2013, Nature.
[2] T. Stinchcombe,et al. KRAS mutation: should we test for it, and does it matter? , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] A. Gingras,et al. Interaction Proteomics Identify NEURL4 and the HECT E3 Ligase HERC2 as Novel Modulators of Centrosome Architecture* , 2012, Molecular & Cellular Proteomics.
[4] Neil J Ganem,et al. DNA breaks and chromosome pulverization from errors in mitosis , 2012, Nature.
[5] J. Palmer,et al. Inflammation-mediated upregulation of centrosomal protein 110, a negative modulator of ciliogenesis, in patients with chronic rhinosinusitis. , 2011, The Journal of allergy and clinical immunology.
[6] A. Balmain,et al. Progressive Genomic Instability in the FVB/KrasLA2 Mouse Model of Lung Cancer , 2011, Molecular Cancer Research.
[7] E. Dmitrovsky,et al. Bexarotene Plus Erlotinib Suppress Lung Carcinogenesis Independent of KRAS Mutations in Two Clinical Trials and Transgenic Models , 2011, Cancer Prevention Research.
[8] B. Dynlacht,et al. Regulating the transition from centriole to basal body , 2011, The Journal of cell biology.
[9] E. Dmitrovsky,et al. Anaphase Catastrophe Is a Target for Cancer Therapy , 2011, Clinical Cancer Research.
[10] M. Harrison,et al. The G1 phase Cdks regulate the centrosome cycle and mediate oncogene-dependent centrosome amplification , 2011, Cell Division.
[11] E. Raymond,et al. Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies. , 2010, European journal of cancer.
[12] L. Chodosh,et al. The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2 , 2010, Oncogene.
[13] E. Dmitrovsky,et al. Targeting the Cyclin E-Cdk-2 Complex Represses Lung Cancer Growth by Triggering Anaphase Catastrophe , 2010, Clinical Cancer Research.
[14] M. Pagano,et al. SCFCyclin F controls centrosome homeostasis and mitotic fidelity through CP 110 degradation , 2010 .
[15] E. Nigg,et al. Control of Centriole Length by CPAP and CP110 , 2009, Current Biology.
[16] David Pellman,et al. A Mechanism Linking Extra Centrosomes to Chromosomal Instability , 2009, Nature.
[17] M. Korc,et al. Pancreatic cancer and precursor pancreatic intraepithelial neoplasia lesions are devoid of primary cilia. , 2009, Cancer research.
[18] D. Pellman,et al. Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. , 2008, Genes & development.
[19] V. Malhotra,et al. CP110 suppresses primary cilia formation through its interaction with CEP290, a protein deficient in human ciliary disease. , 2008, Developmental cell.
[20] E. Golemis,et al. Cell cycle-dependent ciliogenesis and cancer. , 2008, Cancer research.
[21] S. Kitareewan,et al. Cyclin degradation for cancer therapy and chemoprevention , 2007, Journal of cellular biochemistry.
[22] A. Spektor,et al. Cep97 and CP110 Suppress a Cilia Assembly Program , 2007, Cell.
[23] E. Dmitrovsky,et al. Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas , 2007, Proceedings of the National Academy of Sciences.
[24] Laurie A. Smith,et al. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine , 2006, Nature.
[25] Brian David Dynlacht,et al. CP110 cooperates with two calcium-binding proteins to regulate cytokinesis and genome stability. , 2006, Molecular biology of the cell.
[26] B. Yoder,et al. The primary cilium in cell signaling and cancer. , 2006, Cancer research.
[27] J. Minna,et al. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. , 2006, Cancer research.
[28] P. Castagnola,et al. Mutant KRAS, chromosomal instability and prognosis in colorectal cancer. , 2005, Biochimica et biophysica acta.
[29] E. Dmitrovsky,et al. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis. , 2005, Journal of the National Cancer Institute.
[30] M. Hafner,et al. Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instability , 2005, Leukemia.
[31] B. Clurman,et al. Cyclin E in normal and neoplastic cell cycles , 2005, Oncogene.
[32] E. Dmitrovsky,et al. Involvement of UBE1L in ISG15 Conjugation during Retinoid-induced Differentiation of Acute Promyelocytic Leukemia* , 2004, Journal of Biological Chemistry.
[33] F. Stivala,et al. Amplified Centrosomes in Breast Cancer: A Potential Indicator of Tumor Aggressiveness , 2002, Breast Cancer Research and Treatment.
[34] G. Pihan,et al. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. , 2003, Cancer research.
[35] Vahan B. Indjeian,et al. CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells. , 2002, Developmental cell.
[36] H. Naiki,et al. Prognostic significance of cyclin E overexpression in resected non-small cell lung cancer. , 2000, Cancer research.
[37] W. Lingle,et al. Altered centrosome structure is associated with abnormal mitoses in human breast tumors. , 1999, The American journal of pathology.
[38] Carissa A. Sanchez,et al. Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer. , 1991, Proceedings of the National Academy of Sciences of the United States of America.